Unveiling the Therapeutic Potential of the Second Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Tirzepatide vs. Semaglutide: Which Is Better? New Leaf Online Unlocking the Power of Cagrilintide: A Deep Dive Into Dosage Schedules and What to Expect Feast